Home Trending Stocks Timber Pharmaceuticals Inc (TMBR) stock performed well on Wednesday after the recent...

Timber Pharmaceuticals Inc (TMBR) stock performed well on Wednesday after the recent announcement

Timber Pharmaceuticals Inc. (TMBR) stock had a good Wednesday (May 26, 2021). In the morning session, TMBR stock gained 3.42% and close the session at $1.21 per share. It continued its momentum in the after-hours session and further jumped 12.4% and close the day at $1.36 per share. TMBR shares have fallen 56.94% over the last 12 months, and they have lost 6.20% in the past week. Over the past three months, the TMBR stock has declined 37.63%, while over the past six months, it has added 14.15%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Recent News and Developments

Completion of patient enrollment in phase 2b of TMB-001.

On May 26, 2021, Timber Pharmaceuticals, Inc completed the patient enrollment in the Phase 2b CONTROL study assessing TMB-001, a topical pharmaceutical composition of isotretinoin, in patients with moderate to severe subtypes of congenital ichthyosis (CI) on May 31, 2021, to move forward with Phase 3 trial planning.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

  Read More

Recent financial results

On May 11, 2021, Timber Pharmaceuticals, Inc reported its financial results for the first quarter ended March 31, 2021.

Q1 2021 financial highlights

  • Total operating expenses were $1.9 million in Q1 2021 compared to $2.64 million in Q1 2020.
  • In Q1 2021, net loss attributable to common stockholders was $1.91 million compared to $3.6 million in Q1 2020.
  • Basic and diluted net loss per share attributable to common stockholders was $0.05 per share in Q1 2021 compared to $0.56 in Q1 2020.
  • As of March 31, 2021, Timber had $8.5 million cash and common shares outstanding of 36.7 million.

Japanese Patent for Lead Asset TMB-001 granted

On April 28, 2021, Timber Pharmaceuticals reported that it has received a patent for its lead asset, TMB-001 from the Japanese Patent Office. TMB-001is currently being evaluated for the treatment of moderate to severe subtypes of congenital ichthyosis (CI).

New management appointments

On April 23, 2021, Timber Pharmaceuticals appointed John Koconisas Chairman of the Board of Directors. The Company also appointed Edward J. Sitar as Lead Independent Director of the Board and David Cohen, M.D., will serve as Chair of the Company’s new Science and Technology Committee. 

Upcoming Annual Meeting of Shareholders

On April 02, 2021, Timber Pharmaceuticals Inc. announced the date for its Annual Meeting of Shareholders.

The meeting is scheduled for 1:00 pm EDT on Thursday, June 3, 2021.

The company also filed its audited consolidated financial statements for the fiscal year ended December 31, 2020, on Form 10-K with an audit report from its independent accounting firm.

Financial results

On March 23, 2021, Timber Pharmaceuticals Inc reported its financial results for the fiscal year ended December 31, 2020.

Conclusion

The recent news about the patient enrollment in phase2b trial of TMB-001 could be the reason behind its good performance on Wednesday. Still, the company is far away from getting approval for TMB-001 so it is not easy to predict TMBR future stock performance.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam